Aion Therapeutic Inc's (CSE:AION) Dr Winston De La Haye tells Proactive he recently spoke at the international CanEx Psychedelics Summit in Montego Bay, Jamaica, on Aion Therapeutic's signature protocol of starting patients on low microdoses of psilocybin and working them up slowly, with supervision, to therapeutic doses over time. In addition, Dr De La Haye says the group is getting ready to open the Aion International Center for Psychedelic Psychiatry in Kingston, Jamaica.
The Center will initially specialize in the use of psilocybin for the treatment of addiction (tobacco, alcohol and other drug misuse), treatment-resistant depression and anxiety associated with life-threatening illnesses